Low-dose botulinum toxin improves disease activity and quality of life in epidermolysis bullosa simplex

Int J Dermatol. 2023 Aug;62(8):e466-e468. doi: 10.1111/ijd.16605. Epub 2023 Jan 26.

Authors

Maria Melendez¹, Lindsay Osborn¹, Edith Bowers¹

Affiliation

¹ University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

PMID: 36700344
DOI: 10.1111/ijd.16605

No abstract available

Publication types

Letter

MeSH terms

Botulinum Toxins* / therapeutic use
Epidermolysis Bullosa Simplex* / drug therapy
Epidermolysis Bullosa*
Humans
Quality of Life

Substances

Botulinum Toxins